2021 - 2024 Elucidation of oncolytic virus-mediated intratumorl infiltration of immune cells and development of further promotion methods
2020 - 2024 新規アデノウイルス製剤の開発基盤研究
2020 - 2022 Development of human biopsy-derived intestinal organoids monolayers and application for pharmaceutical research
2018 - 2021 Bile Duct Regeneration for Transplantable Functional Liver Graft
2017 - 2021 Development of novel adenovirus vectors through the analysis of the virus with mammalian cells
2014 - 2018 Development of a novel oncolytic virus by regulating the processing of virus-derived non-coding RNA
2014 - 2018 The development of novel adenovirus vectors and application for treatment, prevention, and diagnosis of diseases
2014 - 2016 Creation of iPS-derived Hepatocyte-based Therapeutic Modality Using Liver Micro-organoids
2012 - 2016 Cell-based Therapies Toward Hemophilia Using Autologous Cells from Hemophilic Individuals
2011 - 2015 Development of an efficient gene expression vector utilizing RNA-binding proteins and antisense transcripts
2012 - 2014 Regulation of mammalian neuronal system by a novel microRNA "mirtron".
2011 - 2012 Induction of hematopoietic stem/progenitor cells from mouse pluripotent stemceIIsby inhibitionofanadaptor protein, Lnk.
2011 - 2012 Development of a novel nucleic acid drug targeting sense/antisense transcript pairs
2010 - 2012 The development of the novel targeted adenovirus vectors
2009 - 2012 Development of hybrid therapy of myocardial regenerative medicine and ventricular assist circulation to improve prognosis of heart transplant candidate
2009 - 2010 新規small RNA分子mirtronの生理的機能の解明
2008 - 2010 Development of an adenovirus vector containing microRNA-regulated gene expression system
2006 - 2007 遺伝子改変間葉系幹細胞を用いたがんに対する新しい細胞治療戦略
2005 - 2007 Research of gene transfer into nonhuman promates using novel types of adenovirus vectors
Tomohito Tsukamoto, Haruna Mizuta, Eiko Sakai, Fuminori Sakurai, Hiroyuki Mizuguchi. Evaluation of the correlation between nuclear localization levels and genome editing efficiencies of Cas12a fused with nuclear localization signals. Journal of pharmaceutical sciences. 2024
Fuminori Sakurai, Shunsuke Iizuka, Tomohito Tsukamoto, Aoi Shiota, Kahori Shimizu, Kazuo Ohashi, Hiroyuki Mizuguchi. Transplacental delivery of factor IX Fc-fusion protein ameliorates bleeding phenotype of newborn hemophilia B mice. Journal of Controlled Release. 2024. 374. 415-424
Rika Onishi, Sena Ikemoto, Aoi Shiota, Tomohito Tsukamoto, Akira Asayama, Masashi Tachibana, Fuminori Sakurai, Hiroyuki Mizuguchi. Development of a novel adenovirus serotype 35 vector vaccine possessing an RGD peptide in the fiber knob and the E4 orf 4, 6, and 6/7 regions of adenovirus serotype 5. International journal of pharmaceutics. 2024. 124480-124480
Yanran Tong, Yukiko Ueyama-Toba, Jumpei Yokota, Hayato Matsui, Masaki Kanai, Hiroyuki Mizuguchi. Efficient hepatocyte differentiation of primary human hepatocyte-derived organoids using three dimensional nanofibers (HYDROX) and their possible application in hepatotoxicity research. Scientific reports. 2024. 14. 1. 10846-10846
出口清香, 出口清香, 新谷友啓, 池野喬之, 花岡健二郎, 浦野泰照, 浦野泰照, 浦野泰照, 竹村晃典, 伊藤晃成, et al. Establishment of a CYP3A4-mediated drug evaluation system using human iPS cells and genome editing technology. 日本薬学会年会要旨集(CD-ROM). 2020. 140年会. 28Y-pm13S
日本癌学会
, 日本DDS学会
, 日本薬学会
, 日本遺伝子細胞治療学会
, アメリカ遺伝子細胞治療学会
, The Japan Society of Gene Therapy
, International Society for Stem Cell Research
, 日本分子生物学学会
, 日本薬物動態学会
, 日本再生医療学会
, 肝細胞研究会